Addex Therapeutics Ltd Share Price Today: Live Updates & Key Insights
Addex Therapeutics Ltd share price today is $5.66, up -2.92%. The stock opened at $7.07 against the previous close of $5.83, with an intraday high of $7.07 and low of $7.07.
Addex Therapeutics Ltd Share Price Chart
Addex Therapeutics Ltd
Addex Therapeutics Ltd Share Price Performance
Addex Therapeutics Ltd Institutional Holdings
Addex Therapeutics Ltd Market Status
Addex Therapeutics Ltd Fundamentals
Market Cap 6.97 M
PB Ratio 0.9464
PE Ratio 0.0
Enterprise Value 4.36 M
Total Assets 10.68 M
Volume 891
Addex Therapeutics Ltd Company Financials
About Addex Therapeutics Ltd & investment objective
Company Information Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM); and GABAB PAM for the treatment pain, anxiety, addiction, cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
Organisation Biotechnology
Employees 2
Industry Biotechnology
CEO Mr. Timothy Mark Dyer
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Addex Therapeutics Ltd FAQs
What is the share price of Addex Therapeutics Ltd today?
The current share price of Addex Therapeutics Ltd is $5.66.
Can I buy Addex Therapeutics Ltd shares in India?
Yes, Indian investors can buy Addex Therapeutics Ltd shares by opening an international trading and demat account with Motilal Oswal.
How to buy Addex Therapeutics Ltd shares in India?
You can easily invest in Addex Therapeutics Ltd shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Addex Therapeutics Ltd shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Addex Therapeutics Ltd.
Can I buy fractional shares of Addex Therapeutics Ltd?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Addex Therapeutics Ltd?
Addex Therapeutics Ltd has a market cap of $6.97 M.
In which sector does Addex Therapeutics Ltd belong?
Addex Therapeutics Ltd operates in the Biotechnology sector.
What documents are required to invest in Addex Therapeutics Ltd stocks?
To invest, you typically need:
What is the PE and PB ratio of Addex Therapeutics Ltd?
The PE ratio of Addex Therapeutics Ltd is N/A and the PB ratio is 0.95.